Interesting numbers, sample sizes is so small not sure it's meaningful but still interesting to see. I don't think anyone will ever run a trial without statins, if someone qualifies for statins then you can't take them off them to run a trial and if they don't qualify for statins then they likely have low risk for CVD anyways. I think it makes sense the benefit is bigger for people with higher risk so if you ask would the high statin people come off statins and take Vascepa only see a benefit, probably but what's the point of that.
News 
Market Data 
Discover 
